NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report) shares shot up 4.3% during trading on Wednesday . The company traded as high as $1.97 and last traded at $1.96. 303,553 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 1,478,885 shares. The stock had previously closed at $1.88.
NLS Pharmaceutics Stock Performance
The company has a 50 day moving average of $2.28 and a 200 day moving average of $2.04.
NLS Pharmaceutics Company Profile
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).
Recommended Stories
- Five stocks we like better than NLS Pharmaceutics
- What is diluted earnings per share (Diluted EPS)?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 5 Top Rated Dividend Stocks to Consider
- 3 Steel Stocks Soaring After Tariff Announcements
- What Are Earnings Reports?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
